Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034455836> ?p ?o ?g. }
- W2034455836 endingPage "445" @default.
- W2034455836 startingPage "436" @default.
- W2034455836 abstract "This study was conducted to examine the effects of 5-HT on extracellular signal-regulated kinase 1/2 (Erk1/2) and Akt pathways in prostate cancer (PC) cells.PC cell lines PC-3, Du145, and LNCaP stimulated with 5-HT in the presence of MEK or PI3K inhibitors and 5-HT receptor subtype 1A antagonist were analyzed by Western blotting and immunofluorescence. The proliferation assay BrdU and Boyden chamber were used to determine proliferation and migration, respectively.5-HT dose-dependently induced rapid activation of Erk1/2 in PC-3 and Du145 cells, whereas in LNCaP cells, Erk1/2 phosphorylation was slow and sustained for up to 18 h. Similarly, 5-HT induced phosphorylation of Akt within 1 hour of stimulation, however, Akt phosphorylation was more pronounced in Du145 cells compared with PC-3 or LNCaP cells. The action of 5-HT was inhibited to varying degrees by inhibitors of MAPK and PI3K as well as by a 5-HT receptor subtype 1A antagonist. In addition to proliferation, 5-HT induced migration of PC-3 and Du145 cells, which were alleviated by the aforementioned inhibitors. The effects of 5-HT on LNCaP cells appeared to be related to neuroendocrine-phenotype acquisition and chromogranin A and neuron specific enolase expression.This study addresses the role of 5-HT in Erk1/2 and Akt activation in PC cells. The data presented here identify 5-HT receptors as a novel target in castration-resistant PC. Furthermore, our observations are in line with previous studies, which point towards neuroendocrine factors facilitating progression and migration of prostatic cancer cells in an androgen-deficient environment. Nonetheless, additional studies are warranted to corroborate the role of 5-HTR antagonists as a potential target for anticancer therapy." @default.
- W2034455836 created "2016-06-24" @default.
- W2034455836 creator A5002009939 @default.
- W2034455836 creator A5015634061 @default.
- W2034455836 creator A5029258794 @default.
- W2034455836 creator A5050421886 @default.
- W2034455836 creator A5051364210 @default.
- W2034455836 creator A5071538520 @default.
- W2034455836 date "2011-07-01" @default.
- W2034455836 modified "2023-10-07" @default.
- W2034455836 title "Serotonin activates MAP kinase and PI3K/Akt signaling pathways in prostate cancer cell lines" @default.
- W2034455836 cites W1613602923 @default.
- W2034455836 cites W1969079941 @default.
- W2034455836 cites W1969909043 @default.
- W2034455836 cites W1972383646 @default.
- W2034455836 cites W2000253969 @default.
- W2034455836 cites W2007032888 @default.
- W2034455836 cites W2009197905 @default.
- W2034455836 cites W2014001501 @default.
- W2034455836 cites W2014948512 @default.
- W2034455836 cites W2016543883 @default.
- W2034455836 cites W2019558125 @default.
- W2034455836 cites W2052201038 @default.
- W2034455836 cites W2053103409 @default.
- W2034455836 cites W2058112104 @default.
- W2034455836 cites W2060774821 @default.
- W2034455836 cites W2089626148 @default.
- W2034455836 cites W2089708119 @default.
- W2034455836 cites W2090715921 @default.
- W2034455836 cites W2104339472 @default.
- W2034455836 cites W2124245112 @default.
- W2034455836 cites W2127606003 @default.
- W2034455836 cites W2162147312 @default.
- W2034455836 cites W2170809835 @default.
- W2034455836 cites W2337229884 @default.
- W2034455836 cites W274236614 @default.
- W2034455836 doi "https://doi.org/10.1016/j.urolonc.2009.09.013" @default.
- W2034455836 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19926313" @default.
- W2034455836 hasPublicationYear "2011" @default.
- W2034455836 type Work @default.
- W2034455836 sameAs 2034455836 @default.
- W2034455836 citedByCount "51" @default.
- W2034455836 countsByYear W20344558362012 @default.
- W2034455836 countsByYear W20344558362013 @default.
- W2034455836 countsByYear W20344558362014 @default.
- W2034455836 countsByYear W20344558362015 @default.
- W2034455836 countsByYear W20344558362016 @default.
- W2034455836 countsByYear W20344558362017 @default.
- W2034455836 countsByYear W20344558362018 @default.
- W2034455836 countsByYear W20344558362019 @default.
- W2034455836 countsByYear W20344558362020 @default.
- W2034455836 countsByYear W20344558362021 @default.
- W2034455836 countsByYear W20344558362022 @default.
- W2034455836 countsByYear W20344558362023 @default.
- W2034455836 crossrefType "journal-article" @default.
- W2034455836 hasAuthorship W2034455836A5002009939 @default.
- W2034455836 hasAuthorship W2034455836A5015634061 @default.
- W2034455836 hasAuthorship W2034455836A5029258794 @default.
- W2034455836 hasAuthorship W2034455836A5050421886 @default.
- W2034455836 hasAuthorship W2034455836A5051364210 @default.
- W2034455836 hasAuthorship W2034455836A5071538520 @default.
- W2034455836 hasConcept C104202773 @default.
- W2034455836 hasConcept C11960822 @default.
- W2034455836 hasConcept C121608353 @default.
- W2034455836 hasConcept C126322002 @default.
- W2034455836 hasConcept C128240485 @default.
- W2034455836 hasConcept C134018914 @default.
- W2034455836 hasConcept C170493617 @default.
- W2034455836 hasConcept C184235292 @default.
- W2034455836 hasConcept C185592680 @default.
- W2034455836 hasConcept C2776438761 @default.
- W2034455836 hasConcept C2779723316 @default.
- W2034455836 hasConcept C2780044377 @default.
- W2034455836 hasConcept C502942594 @default.
- W2034455836 hasConcept C55493867 @default.
- W2034455836 hasConcept C57074206 @default.
- W2034455836 hasConcept C62112901 @default.
- W2034455836 hasConcept C62478195 @default.
- W2034455836 hasConcept C71924100 @default.
- W2034455836 hasConcept C75217442 @default.
- W2034455836 hasConcept C86554907 @default.
- W2034455836 hasConcept C86803240 @default.
- W2034455836 hasConcept C95444343 @default.
- W2034455836 hasConcept C96232424 @default.
- W2034455836 hasConceptScore W2034455836C104202773 @default.
- W2034455836 hasConceptScore W2034455836C11960822 @default.
- W2034455836 hasConceptScore W2034455836C121608353 @default.
- W2034455836 hasConceptScore W2034455836C126322002 @default.
- W2034455836 hasConceptScore W2034455836C128240485 @default.
- W2034455836 hasConceptScore W2034455836C134018914 @default.
- W2034455836 hasConceptScore W2034455836C170493617 @default.
- W2034455836 hasConceptScore W2034455836C184235292 @default.
- W2034455836 hasConceptScore W2034455836C185592680 @default.
- W2034455836 hasConceptScore W2034455836C2776438761 @default.
- W2034455836 hasConceptScore W2034455836C2779723316 @default.
- W2034455836 hasConceptScore W2034455836C2780044377 @default.
- W2034455836 hasConceptScore W2034455836C502942594 @default.
- W2034455836 hasConceptScore W2034455836C55493867 @default.